Monitoring plasmatic concentrations of efavirenz for prediction of clinical outcomes in people living with HIV
Author(s) -
Thaís Lorenna Souza Sales,
Nathália Soares Simões,
Gustavo Machado Rocha,
Keyller Bastos Borges,
Cristiane Aparecida Menezes de Pádua,
Eduardo Sérgio da Silva,
Cristina Sanches
Publication year - 2022
Publication title -
revista de ciências farmacêutica básica e aplicadas - rcfba
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.101
H-Index - 16
eISSN - 2179-443X
pISSN - 1808-4532
DOI - 10.4322/2179-443x.0771
Subject(s) - efavirenz , adverse effect , medicine , receiver operating characteristic , human immunodeficiency virus (hiv) , plasma concentration , pharmacokinetics , area under the curve , antiretroviral therapy , therapeutic drug monitoring , pharmacology , viral load , immunology
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom